(PharmaNewsWire.Com, December 27, 2017 ) According to the report Diabetic Retinopathy Market, published by Market Data Forecast, the Latin America market is projected to reach USD 790 million by 2021, at a CAGR of 7.69% from 2016 to 2021.
Diabetic retinopathy also referred to as diabetic eye disease is a medical condition in which damage occurs to the eyes due to diabetes, which is also a leading cause of blindness. It occurs to about 80% of people who have had diabetes for more than 20 years. More than 90% of them could have been prevented if proper monitoring of their eyes was done. The probability of someone getting this disease increases with the time for which the person has been suffering from diabetes. It is the leading cause of blindness for people aged between 20 to 64 years.
In the first stages of this disease which is called non-proliferative diabetic retinopathy (NDPR) there are no symptoms, the signs are not visible to the eye and there are no changes in vision to the person. The only way to detect this first stage Is through fundus photography in which microaneurysms which are basically microscopic blood filled bulges in the artery walls can be seen. Narrowing of the blocked retinal walls can also be seen. In the second stage abnormal new blood vessels form behind the back of eye, which can burst, bleed and blur the vision of the person affected. These type of haemorrhages can happen more than once even in sleep.
Latin America Diabetic Retinopathy Market: Drivers & Restraints Among the forces which are driving the market are great increases in incidence of diabetes cases in Latin America region. Other drivers include rapid growth of healthcare infrastructure and growing development of government and non-government initiatives for increasing awareness about managing diabetes in population. Rising geriatric demographics and companies trying to get hold in this region are the other factors driving the growth of this market.
Latin America Diabetic Retinopathy Market: Segmentation By Indication Non-Proliferative Diabetic Retinopathy (NPDR) o Mild o Moderate o Severe Proliferative Diabetic Retinopathy (PDR) By Treatment Anti-Vascular Endothelial Growth Factor (VEGF) drug Intraocular Steroid Injection Laser Surgery Vitrectomy
By End Users Hospitals Ophthalmic Clinics Ambulatory Surgical Centres
Latin America Diabetic Retinopathy Market: Overview Diabetic retinopathy (DR) is an eye disease related with diabetic patients. The disease happens when there is harm to the retina because of diabetes. Without opportune treatment, the disease may prompt seeping in the eyes, shady vision, and may even decimate the retina. DR is among the normal reason for loss of vision in the diabetic populace; in the end prompting visual impairment. Increment in commonness of diabetes, ascend in geriatric populace, development in rate of visual impairment because of diabetes, and enlarge of concentrate on mindfulness that encourages early conclusion to control the diseases drive the market. Be that as it may, this development is restricted by deficiency of gifted ophthalmologists, and expanded endorsement time for drugs. On the other hand, rise of consolidated treatments for treatment of diabetic macular edema and the developing markets of the Latin America locales are required to give a few chances to showcase development amid the figure time frame.
Latin America Diabetic Retinopathy Market: Region-wise Outlook The Latin America Diabetic Retinopathy Market is geographically segmented into Brazil, Argentina and Mexico. Owing to rising geriatric population and increased incidence of diabetic cases in this region the market is expected to propel forward in the forecast period.
Key Questions Answered What is the current and future Diabetic Retinopathy market outlook in Latin America? What trends are affecting the Latin American market? What is the competitive landscape and market share of major players in the Diabetic Retinopathy space in Latin America? What are the key, high growth markets that Diabetic Retinopathy manufacturers should expand into? Which market segments are growing the fastest? What are the unmet needs with the Diabetic Retinopathy currently on the market? How will emerging technologies fulfil these unmet needs? What is physician perception and market outlook of Diabetic Retinopathy? What are the challenges and barriers that have hindered widespread adoption of Diabetic Retinopathy?
Latin America Diabetic Retinopathy Market: Key Players The major companies in Diabetic Retinopathy treatment market are Bayer AG, Pfizer Inc., Hoffmann-La Roche ltd, Regeneron Pharmaceutical Inc., Novartis AG, Valeant Pharmaceutical International Inc., Abbott Laboratories Inc., Alimera Science Inc. and Ampio Pharmaceuticals Inc.
Reasons to buy Latin America Diabetic Retinopathy Market Report: Regional and country-level analysis and forecasts of the study market; providing Insights on the geographical areas in which this industry is prospering Segment-level analysis on basis of product type, application, colour along with market size forecasts and y-o-y estimations to detect key areas of industry growth in detail Identification of key drivers, restraints, opportunities, and challenges (DROC) in the market and their impact on shifting market dynamics Study of macro and micro environmental factors that affect the market presented in an extensive strategic analyses section containing PESTLE and Porters Five Forces Analyses A comprehensive listing of key market players along with company overview, product portfolios, key financial information (subjected to availability), SWOT analysis and Analyst overview to study and sustain the market environment Competitive landscape analysis listing out the mergers, acquisitions, collaborations in the field along with new product launches, comparative financial studies and recent developments in the market by the major companies Expertly devised Market Outlook along with Investment opportunities to provide both individuals and organizations a strong financial foothold in the market
About Market Data Forecast: Market Data Forecast is a firm working in the area of market research and business intelligence. With rich experience in research across various business domains, they cater to the needs of both individual and corporate clients. From all-encompassing umbrella markets to extremely specific niche markets covering all the major regions across the globe as part of the research scope, their research services offer one of a kind specialities with competitive pricing options. For more information, kindly visit, www.marketdataforecast.com.
We are pleased to offer you this exciting, new, and entirely free professional resource. Visit our Free Biotechnology & Pharmaceuticals resource center today to browse our selection of 600+ complimentary Biotechnology & Pharmaceuticals magazines, white papers, webinars, podcasts, and more. Get popular titles including:
